ELANCO ANIMAL HEALTH INC (5EA.DE) Forecast, Price Target & Analyst Ratings

FRA:5EA • US28414H1032

Current stock price

19.75 EUR
-0.3 (-1.52%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ELANCO ANIMAL HEALTH INC (5EA.DE).

Forecast Snapshot

Consensus Price Target

Price Target
€22.49
+ 13.88% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 5, 2026
Period
Q1 / 2026
EPS Estimate
$0.35
Revenue Estimate
1.314B
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
85.45%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
€22.49
Upside
+ 13.88%
From current price of €19.75 to mean target of €22.49, Based on 22 analyst forecasts
Low
€18.52
Median
€22.95
High
€26.25

Price Target Revisions

1 Month
0.00%
3 Months
1.90%

Price Target Summary

22 Wall Street analysts provided a forecast for the next 12 months for 5EA.DE. The average price target is 22.49 EUR. This implies a price increase of 13.88% is expected in the next year compared to the current price of 19.75.
The average price target has been revised upward by 1.9% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

5EA Current Analyst Rating5EA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

5EA Historical Analyst Ratings5EA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20

Analyst Ratings Consensus

ChartMill Buy Consensus
85.45%
5EA.DE was analyzed by 22 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about 5EA.DE.
In the previous month the buy percentage consensus was at a similar level.
5EA.DE was analyzed by 22 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2021-05-11Gabelli & Co.Upgrade Hold -> Buy
2021-05-11BarclaysUpgrade Underweight -> Equal-Weight
2021-04-15StifelInitiate Buy
2021-03-22Gabelli & Co.Downgrade Buy -> Hold
2021-02-26Credit SuisseUpgrade Neutral -> Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 5, 2026
Period
Q1 / 2026
EPS Estimate
$0.35
Revenue Estimate
1.314B
Revenue Q2Q
10.14%
EPS Q2Q
-4.70%
Number of Analysts
15

Next Earnings Revisions

Revenue (1 Month)
0.69%
Revenue (3 Months)
0.61%
EPS (1 Month)
-1.36%
EPS (3 Months)
-1.36%

Next Earnings Summary

5EA.DE is expected to report earnings on 5/5/2026. The consensus EPS estimate for the next earnings is 0.35 EUR and the consensus revenue estimate is 1.31B EUR.
The next earnings revenue estimate has been revised upward by 0.61% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
5EA.DE revenue by date.5EA.DE revenue by date.
4.417B
0.14%		4.439B
0.50%		4.715B
6.22%		5.121B
8.61%		5.372B
4.90%		5.632B
4.84%		5.853B
3.92%		6.037B
3.14%		6.206B
2.80%		6.377B
2.76%		6.428B
0.80%
EBITDA
YoY % growth
5EA.DE ebitda by date.5EA.DE ebitda by date.
1.02B
-4.32%		913M
-10.49%		932M
2.08%		1.001B
7.40%		1.092B
9.09%		1.194B
9.34%		1.266B
6.03%		1.33B
5.06%		1.389B
4.44%		1.467B
5.62%		1.454B
-0.89%
EBIT
YoY % growth
5EA.DE ebit by date.5EA.DE ebit by date.
326M
-15.10%		251M
-23.01%		252M
0.40%		802.82M
218.58%		896.26M
11.64%		998.7M
11.43%		1.105B
10.64%		1.163B
5.25%		1.217B
4.64%		1.289B
5.92%		1.262B
-2.09%
Operating Margin
5EA.DE operating margin by date.5EA.DE operating margin by date.
7.38%5.65%5.34%15.68%16.68%17.73%18.88%19.26%19.61%20.21%19.63%
EPS
YoY % growth
5EA.DE eps by date.5EA.DE eps by date.
0.89
-19.82%		0.91
2.25%		0.95
4.40%		1.05
10.73%		1.18
12.42%		1.34
13.21%		1.51
12.57%		1.54
2.20%		1.63
5.63%		1.74
6.90%		1.66
-4.40%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28
EPS
Q2Q % growth		0.35
-4.70%		0.30
13.56%		0.20
6.93%		0.18
38.59%		0.38
8.67%		0.33
11.18%		0.22
9.45%		0.20
13.22%		0.42
9.14%		0.37
11.86%		0.22
0.92%
Revenue
Q2Q % growth		1.314B
10.14%		1.343B
8.22%		1.216B
6.95%		1.17B
2.27%		1.356B
3.20%		1.405B
4.62%		1.275B
4.85%		1.223B
4.53%		1.452B
7.08%		1.511B
7.54%		1.361B
6.75%
EBITDA
Q2Q % growth		306.82M
8.80%		270.78M
-34.75%		210.96M
-60.42%		195.2M
-72.07%		330.12M
7.59%		298.22M
10.13%		227.52M
7.85%		205.44M
5.25%		N/AN/AN/A
EBIT
Q2Q % growth		274.44M
126.81%		234.31M
175.66%		175.07M
548.41%		159.36M
738.74%		304.43M
10.93%		261.42M
11.57%		187.5M
7.10%		159.18M
-0.11%		N/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

5EA.DE Yearly Revenue VS Estimates5EA.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
5EA.DE Yearly EPS VS Estimates5EA.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0.5 1 1.5

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
12.11%
EPS Next 5 Year
10.15%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
5.76%
Revenue Next 5 Year
4.86%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
18.81%
EBIT Next 5 Year
13.31%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ELANCO ANIMAL HEALTH INC / 5EA.DE Forecast FAQ

What do analysts expect the price target to be for ELANCO ANIMAL HEALTH INC (5EA.DE)?

22 analysts have analysed 5EA.DE and the average price target is 22.49 EUR. This implies a price increase of 13.88% is expected in the next year compared to the current price of 19.75.

What is the next earnings date for 5EA stock?

ELANCO ANIMAL HEALTH INC (5EA.DE) will report earnings on 2026-05-05, before the market open.

What are the consensus estimates for ELANCO ANIMAL HEALTH INC (5EA.DE) next earnings?

The consensus EPS estimate for the next earnings of ELANCO ANIMAL HEALTH INC (5EA.DE) is 0.35 EUR and the consensus revenue estimate is 1.31B EUR.

How do analysts rate ELANCO ANIMAL HEALTH INC (5EA.DE)?

The consensus rating for ELANCO ANIMAL HEALTH INC (5EA.DE) is 85.4545 / 100 . This indicates that analysts generally have a positive outlook on the stock.